ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

April 15, 1988

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001